The Cooper Companies, Inc. (NASDAQ:COO – Get Free Report) has been given an average rating of “Moderate Buy” by the twelve brokerages that are covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. The average 12-month target price among brokers that have covered the stock in the last year is $86.6364.
COO has been the topic of a number of research analyst reports. Stifel Nicolaus reduced their price objective on shares of Cooper Companies from $90.00 to $85.00 and set a “buy” rating on the stock in a research note on Thursday, August 28th. Needham & Company LLC reiterated a “buy” rating and set a $94.00 price objective on shares of Cooper Companies in a research note on Thursday, August 28th. JPMorgan Chase & Co. reduced their price objective on shares of Cooper Companies from $76.00 to $66.00 and set a “neutral” rating on the stock in a research note on Thursday, August 28th. Mizuho reduced their price objective on shares of Cooper Companies from $105.00 to $90.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 16th. Finally, UBS Group upgraded shares of Cooper Companies to a “buy” rating in a research note on Tuesday, June 17th.
Insider Buying and Selling at Cooper Companies
Hedge Funds Weigh In On Cooper Companies
Large investors have recently made changes to their positions in the business. Zions Bancorporation National Association UT bought a new position in shares of Cooper Companies during the 1st quarter valued at about $33,000. City Holding Co. acquired a new position in shares of Cooper Companies in the first quarter worth about $34,000. GKV Capital Management Co. Inc. acquired a new position in shares of Cooper Companies in the first quarter worth about $40,000. J.Safra Asset Management Corp boosted its holdings in shares of Cooper Companies by 204.8% in the second quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company’s stock worth $36,000 after buying an additional 340 shares during the period. Finally, CYBER HORNET ETFs LLC acquired a new position in shares of Cooper Companies in the second quarter worth about $36,000. Institutional investors own 24.39% of the company’s stock.
Cooper Companies Price Performance
Shares of COO stock opened at $68.00 on Tuesday. The company has a market capitalization of $13.52 billion, a PE ratio of 33.50, a price-to-earnings-growth ratio of 1.79 and a beta of 0.97. The firm has a fifty day simple moving average of $70.54 and a 200-day simple moving average of $74.81. The company has a current ratio of 2.12, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. Cooper Companies has a twelve month low of $61.78 and a twelve month high of $111.44.
Cooper Companies (NASDAQ:COO – Get Free Report) last posted its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $1.07 by $0.03. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The firm had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same period in the prior year, the firm posted $0.96 EPS. The firm’s revenue was up 5.7% compared to the same quarter last year. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Equities research analysts anticipate that Cooper Companies will post 3.98 earnings per share for the current fiscal year.
Cooper Companies announced that its Board of Directors has authorized a share buyback program on Wednesday, September 17th that allows the company to buyback $2.00 billion in outstanding shares. This buyback authorization allows the medical device company to repurchase up to 15.4% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s board believes its shares are undervalued.
Cooper Companies Company Profile
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Read More
- Five stocks we like better than Cooper Companies
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- How The Weak Dollar Is Fueling These Global Stock Surges
- What Are Dividend Challengers?
- 3 Recession-Ready Stocks That Thrive When the Economy Sputters
- How to find penny stocks to invest and tradeĀ
- 3 Automation-Focused Stocks Flying Under the Radar
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.